Lataa...
In Silico Screening for PTPN22 Inhibitors: Active Hits From an Inactive Phosphatase Conformation
A gain-of-function mutant of the lymphoid phosphatase Lyp (PTPN22) has recently been implicated with type 1 diabetes and other autoimmune diseases, suggesting that small-molecule inhibitors of Lyp could be useful for the treatment of autoimmunity. Virtual ligand screening (VLS) was applied in the se...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3102533/ https://ncbi.nlm.nih.gov/pubmed/19177473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.200800375 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|